JSC Dori-Darmon announced the arrival of the Rapid Test VivaDiagTMPro SARS-CoV-2Ag in the network of social pharmacies.

According to the company, the test is designed for rapid and qualitative determination of the nucleocapsid protein antigen from SARS-CoV-2 in humans.

The test is for in vitro diagnostic use only (medical tests performed on samples taken from the body for analysis) and only provides an initial screening test result. This test is intended for home use with self-collected nasal swab specimens from individuals aged 16-69. Sample collection and testing in persons under 16 and over 69 should be supervised by an adult.

The test package contains instructions for use.

UzA